Introduction
Age-associated human diseases are a major burden for developed society. The underlying factors include environmental stressors and hereditary vulnerabilities. Whether toxic life events repeatedly overwhelm the defense capacity of an organism will depend on specific genes and their variation as well as on nutrient availability and stored energy. In particular, with the domestication of endosymbionts of bacterial origin, namely, mitochondria and chloroplasts, it must have become important for eukaryotic cells to expand their genetic machinery to compensate the deleterious consequences of chronic oxidative stress and carbohydrate/lipid depletion. The repair of fragile single-stranded RNA had to be ensured, and the recruitment of alternative fuels from storage [ 2 5 9 _ T D $ D I F F ] needed to be managed. Besides, cell growth had to be repressed during periods of excessive bioenergetic demands or of nutrient starvation. The chronic dysregulation of these processes would prominently affect cells with high rates of mitochondrial respiration such as neurons, which cannot undergo cell division and will insidiously accumulate the deleterious consequences during the organism's life span. Ataxin-2 (human gene symbol ATXN2) is now emerging as a key factor for human neurodegenerative diseases, and it appears to act within this machinery of nutrient disposal and damage repair.
Ataxin-2 Homologs in Phylogenesis
During phylogenetic evolution, a protein with a combination of domains similar to ATXN2 was never found among prokaryotes, but it appears in every eukaryotic organism, irrespective of whether it contains mitochondria or chloroplasts. Land plants have several copies of the gene Trends Ataxin 2 (ATXN2) orthologs containing Lsm, PAM2, and PRD motifs are now identified from man to yeast and plants.
Global growth repression in stress periods by ATXN2 via inhibition of mTORC1 phosphorylation signals was recently shown in yeast, worms, and man.
Compensatory breakdown of lipids via ATXN2 was observed in worms, flies, and mammals.
Both effects are modulated by specific mitochondrial matrix enzymes (e.g., IVD, ACADS) under the control of ATXN2. Factors responsible for elimination of dysfunctional mitochondria and bacteria (e.g., PINK1) are also governed by ATXN2, so it may have contributed to eukaryotic origin.
Depletion of ATXN2 levels is neuroprotective in ALS and in SCA2 [ 2 5 8 _ T D $ D I F F ] mouse models; this confirms previous observations in yeast and flies.
